STAT

Opinion: The (relative) risk in misinterpreting health spending statistics

A closer look at the absolute numbers tells a different story than the headlines about health spending statistics.

Humans are generally lousy when it comes to understanding statistics. We tend to panic over remote risks (shark attacks are on the rise!) but dismiss larger but more mundane dangers like pedestrian deaths (2016 was the deadliest year on record in the U.S.).

That’s especially true when those risks are presented as relative risks, rather than absolute numbers. An 11 percent jump in shark attacks sounds substantial, but it means nine or so additional bites. Last year’s 11 percent jump in pedestrian fatalities meant hundreds more lives lost. Guess which topic received

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks